ATC Group: N03AX24 Cannabidiol

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N03AX24 in the ATC hierarchy

Level Code Title
1 N Nervous system
2 N03 Antiepileptics
3 N03A Antiepileptics
4 N03AX Other antiepileptics
5 N03AX24

Active ingredients in N03AX24

Active Ingredient Description
Cannabidiol

Cannabidiol is indicated for the treatment of seizures associated with Lennoxโ€‘Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC) in patients 1 year of age and older.

Related product monographs

Title Information Source Document Type  
EPIDIOLEX Oral solution FDA, National Drug Code (US) MPI, US: SPL/PLR
EPIDYOLEX Oral solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Australia (AU)

Austria (AT)

Estonia (EE)

Finland (FI)

Ireland (IE)

Israel (IL)

Lithuania (LT)

Poland (PL)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.